Explore

Trendline Trendline
Veracyte to Engage in June 2026 Investor Conferences, Highlighting Diagnostic Innovations

Veracyte to Engage in June 2026 Investor Conferences, Highlighting Diagnostic Innovations

Veracyte to Engage in June 2026 Investor Conferences, Highlighting Diagnostic Innovations
Trendline Trendline
Veracyte to Present at June 2026 Investor Conferences, Showcasing Cancer Diagnostics Innovations

Veracyte to Present at June 2026 Investor Conferences, Showcasing Cancer Diagnostics Innovations

Veracyte to Present at June 2026 Investor Conferences, Showcasing Cancer Diagnostics Innovations
Trendline Trendline
Akari Therapeutics Reports Increased Net Loss in Q1 2026

Akari Therapeutics Reports Increased Net Loss in Q1 2026

Akari Therapeutics Reports Increased Net Loss in Q1 2026
Trendline Trendline
Verdiva Bio to Present Preclinical Data on Obesity Drug Candidates at ADA Scientific Sessions

Verdiva Bio to Present Preclinical Data on Obesity Drug Candidates at ADA Scientific Sessions

Verdiva Bio to Present Preclinical Data on Obesity Drug Candidates at ADA Scientific Sessions
Trendline Trendline
Veracyte Announces Participation in June 2026 Investor Conferences

Veracyte Announces Participation in June 2026 Investor Conferences

Veracyte Announces Participation in June 2026 Investor Conferences
Trendline Trendline
Verdiva Bio to Present Obesity Drug Data at ADA Scientific Sessions

Verdiva Bio to Present Obesity Drug Data at ADA Scientific Sessions

Verdiva Bio to Present Obesity Drug Data at ADA Scientific Sessions
Trendline Trendline
Parabilis Biotech Files for IPO to Fund Cancer Drug Trials

Parabilis Biotech Files for IPO to Fund Cancer Drug Trials

Parabilis Biotech Files for IPO to Fund Cancer Drug Trials
Trendline Trendline
Palatin Technologies to List on Nasdaq, Aiming for Enhanced Visibility and Liquidity

Palatin Technologies to List on Nasdaq, Aiming for Enhanced Visibility and Liquidity

Palatin Technologies to List on Nasdaq, Aiming for Enhanced Visibility and Liquidity
Trendline Trendline
Palatin Technologies to List on Nasdaq, Enhancing Market Visibility

Palatin Technologies to List on Nasdaq, Enhancing Market Visibility

Palatin Technologies to List on Nasdaq, Enhancing Market Visibility
Trendline Trendline
Halia Therapeutics Expands Board with New Executive Chairman and Directors to Drive Growth

Halia Therapeutics Expands Board with New Executive Chairman and Directors to Drive Growth

Halia Therapeutics Expands Board with New Executive Chairman and Directors to Drive Growth
Trendline Trendline
Halia Therapeutics Expands Board with New Executive Chairman and Directors Amid Strategic Growth

Halia Therapeutics Expands Board with New Executive Chairman and Directors Amid Strategic Growth

Halia Therapeutics Expands Board with New Executive Chairman and Directors Amid Strategic Growth
Trendline Trendline
Dolby Laboratories to Present at Key Investor Conferences in June 2026

Dolby Laboratories to Present at Key Investor Conferences in June 2026

Dolby Laboratories to Present at Key Investor Conferences in June 2026